Titlebook: Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures; Boris R. Minev Book 2011 Springer Scienc

NOCT

growth-factor

可商量

无动于衷

integral

Alkylating Agentsh are preferentially activated by tumor cells have been developed. Among those, TLK286, a glutathione S-transferase P1–1 activated prodrug that elicits cytotoxicity against cancer cells but has bone marrow sparing activities, is one example. This compound may be a forerunner of new anticancer drugs

误传

Topoisomerase I Inhibitors – The Camptothecinsation including SN-38, 9-aminocamptothecin (9-AC), 9-Nitrocamptothecin (9-NC), lurtotecan (GI-47211), rubitecan, OSI-211, exatecan mesylate (DX8951f), diflomotecan (BN80915), gimatecan (ST1481), CKD-602, DB-67, and karenitecin (BNP1350). The advancement of these agents and further development within

Affable

Folate Antagonists-based therapeutic uses, common toxicities, and problems with resistance. We briefly review other folate antagonists as well. In conclusion, methotrexate and other antifolates are important cytotoxic drugs used alone or in combination with other medications for the treatment of a wide variety of mal

Gerontology

缺乏

偏狂症

Effects of Cancer Chemotherapy on Gonadal Functionts currently receive chemotherapy than ever before and, of greater significance, many more individuals are cured of their tumors and survive to experience the potential late adverse effects of such treatment. Among these, infertility and mutagenesis are often of particular concern to cancer survivor